Clearance Summary
BIOSPACE BODY COMPOSITION ANALYZERS, MODEL INBODY 230 received FDA 510(k) clearance under submission number K062603, sponsored by Biospace Corporation Limited. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2007-02-15.
- Submission: K062603
- Applicant / Sponsor: Biospace Corporation Limited
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.2770
- Decision date: 2007-02-15
Classification & Regulation
This clearance is catalogued under FDA product code MNW and 21 CFR 870.2770, within the Cardiovascular review panel as a Class II device.